can you od on glp 1 GLP-1 receptor agonists show promise in treating substance use disorders GLP-1 receptor agonists show promise
Description
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide, are widely used in the treatment of metabolic disorders, including type 2 diabetes (T2D) and obesity
The business case
We conducted a systematic review and meta-analysis to assess the efficacy and safety of tirzepatide for type 2 diabetes
It is also advised to start with 1 capsule for 3-5 days to assess comfort of the powerful formula designed as a fat burner for men and women
Minimally processed, no artificial ingredients
